Document is current
Any future updates will be listed below
-
Authors
Levinsen, Anne Katrine Graudal https://orcid.org/0000-0003-0906-1873
Ammitzbøll, Gunn
Kjaer, Trille Kristina
Borre, Michael
Larsen, Signe Benzon
Dalton, Susanne Oksbjerg
-
Funding
Funding for this research was provided by:
Kræftens Bekæmpelse (R364-A21129)
Kræftens Bekæmpelse (R324-A18053)
Kræftens Bekæmpelse (R269-A15811)
Kirsten og Freddy Johansens Fond
Novo Nordisk Fonden (NNF18OC0052543)
Helsefonden (20-B-0434)
- License Information
-
More Information
Article History
Received: 13 May 2025
Accepted: 8 April 2026
First Online: 15 April 2026
Declarations
:
: The SEQUEL study is approved by the National Board of Health Data (Region Zealand (REG-059–2021)). Ethical review and approval were waived for this study, as no human biological material was included in the project. The study was registered in the Danish Cancer Society Research Database (2019-DCRC-0066). We obtained informed consent from all participants in the study. Data were stored and protected following the guidelines of the Danish legislation regarding GDPR.
: AKGL had full access to all the data in the study and takes full responsibility for the integrity of the data and the accuracy of the data analysis.
: The authors declare no competing interests.
